RxGenomix understands that an employer’s most important assets are their employees and the success of the company largely rests on the health of the individuals. No matter your industry, keeping your employees healthy and productive is a significant investment and navigating healthcare is a complicated and costly undertaking for even the most sophisticated employers. Most are desperately searching for sustainable solutions that produce real value for both the organization, and their employees. That’s where pharmacogenomics (PGx) comes in.
PGx testing can give healthcare providers unprecedented support in their clinical decision making when medication therapy is called for. More than 91%of people carry at least one actionable drug-gene mutation that could help the prescriber decide which medications will provide the best result, and at what dosages. And more effective therapies equal healthier employees. It’s that simple.
What Can RxGenomix Do for My Company?
Appropriately guided and implemented PGx programs can produce happier, more engaged employees who are more productive and generate lower overall healthcare costs.
RxGenomix understands that, just like your employees are unique, so is your company. That’s why we work with employers’ own data to develop customized feasibility studies, ROI analyses and even risk-stratified reports that help you prioritize your PGx program efforts for the greatest benefit.
By combining our robust analytical tools, clinical application process and a talented pharmacist network, RxGenomix can positively enhance your commitment to your employees’ health and wellness while saving you money.
Behavioral health is just one area for which PGx testing is relevant, and one of the hardest to treat effectively. In a 2013 study published in Translational Psychiatry, however, researchers found that routine PGx testing for employees who were on at least one of 26 common antidepressant and antipsychotic medications could speed the time to effective therapy and:
- reduce total healthcare visits by 69 percent
- reduce medical-related absenteeism to one third of current rates
- reduce disability claims to one fourth of current rates
For every dollar spent treating depression, an additional $4.70 is spent on direct and indirect costs of related illnesses. Another $1.90 is spent on a combination of reduced workplace productivity and the economic costs associated with suicide directly linked to depression. *
Contact RxGenomix to learn more about how to improve the overall health of the people you count on while reducing your overall healthcare costs.
*Published on www.scientificamerican.com on February 25, 2015 – Paul E. Greenberg